BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
42 hedge funds and large institutions have $17.1M invested in BRAINSTORM CELL THERAPUTC in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 48 → 42 (-6)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
42
Holding in Top 10
–
Calls
$3.65M
Puts
$435K
Top Buyers
| 1 | +$254K | |
| 2 | +$194K | |
| 3 | +$170K | |
| 4 |
Millennium Management
New York
|
+$148K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$136K |
Top Sellers
| 1 | -$516K | |
| 2 | -$280K | |
| 3 | -$70K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$67K |
| 5 |
VF
Virtu Financial
New York
|
-$57K |